“In the construction of Recovery any imperfection, no matter how small, in the foundation threatens the whole project now, and in the future. Success of the project depends on true and accurate information “
– Mark Dubé, MD, UPTru’s Founder and President
Our Innovation
UPTru’s lead innovation is a patented methodology that identifies 100% of specimens falsified by specimen substitution. Our approach enables confirmation of the authenticity of urine samples in an inexpensive and timely manner. Our simple process respects patients’ right to privacy while significantly improving the utility of point of care urine drug testing in the clinic and workplace.
The Opportunity
The volume of point of care urine drug tests has grown exponentially in the last two decades. Addiction medicine, once a highly specialized branch of medicine, now encompasses all of medicine from neonatology to geriatrics. Point of care urine drug testing has become one of the pillars of Addiction Medicine costing an estimated $8.5 B annually. Despite major advances in drug testing technology, the utility of urine drug testing is compromised by the falsification of results through covert substitution of urine samples. This is estimated to invalidate as many as 7% of all urine drug tests.